Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Pulmostem by Amniotics for Influenzavirus A Infections: Likelihood of Approval
Pulmostem is under clinical development by Amniotics and currently in Phase II for Influenzavirus A Infections. According to GlobalData, Phase...
Data Insights
Pulmostem by Amniotics for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval
Pulmostem is under clinical development by Amniotics and currently in Phase II for Respiratory Syncytial Virus (RSV) Infections. According to...